Birth characteristics and Wilms tumors in children in the Nordic countries: A register-based case–control study (original) (raw)

Abstract

Little is known about causes of Wilms tumor. Because of the young age at diagnosis, several studies have looked at various birth characteristics. We conducted a registry-based case-control study involving 690 cases of Wilms tumor aged 0-14 years, occurring in Denmark, Finland, Norway or Sweden during 1985-2006, individually matched to five controls drawn randomly from the Nordic childhood population. Information on birth characteristics was obtained from the population-based medical birth registries. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) using conditional logistic regression analysis. We observed a distinct association between Wilms tumor and high birth weight (4 kg) for girls (OR 1.97, CI 1.50-2.59) but not for boys (1.04, 0.78-1.38); overall, the OR was 1.43 (1.17-1.74). Among girls, risk increased by 28% (15-42%) per 500 g increase in birth weight. Large-for-gestational age girls also had a higher risk (2.48, 1.51-4.05), whereas no effect was seen for boys (1.12, 0.60-2.07). An association was seen with Apgar score at 5 min < 7 for both sexes combined (5.13, 2.55-10.3). ORs close to unity were seen for parental age and birth order. In our large-scale, registry-based study, we confirmed earlier observations of an association between high birth weight and risk of Wilms tumor, but we found an effect only in girls. The higher risk of infants with low Apgar score might reflect hypoxia causing cell damage, adverse side effects of neonatal treatment or reverse causation as low Apgar score might indicate the presence of a tumor.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (46)

  1. Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol 1993;21:172-81.
  2. Green DM, D'Angio GJ, Beckwith JB, Breslow NE, Grundy PE, Ritchey ML, Thomas PR. Wilms tumor. CA Cancer J Clin 1996;46:46-63.
  3. Beckwith JB. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet 1998;79:268-73.
  4. Pastore G, Znaor A, Spreafico F, Graf N, Pritchard-Jones K, Steliarova-Foucher E. Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2103-14.
  5. Leisenring WM, Breslow NE, Evans IE, Beckwith JB, Coppes MJ, Grundy P. Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess. Cancer Res 1994;54:4680-3.
  6. Breslow NE, Beckwith JB, Perlman EJ, Reeve AE. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer 2006;47:260-7.
  7. Daniels JL, Pan IJ, Olshan AF, Breslow NE, Bunin GR, Ross JA; Children's Oncology Group. Obstetric history and birth characteristics and Wilms tumor: a report from the Children's Oncology Group. Cancer Causes Control 2008; 19:1103-10.
  8. Lindblad P, Zack M, Adami HO, Ericson A. Maternal and perinatal risk factors for Wilms' tumor: a nationwide nested case- control study in Sweden. Int J Cancer 1992;51:38-41.
  9. Jepsen P, Olsen ML, Mellemkjaer L, Olsen JH, Sørensen HT. A registry-based study of gender, fetal growth, and risk of Wilms tumor. Pediatr Hematol Oncol 2004;21:435-9.
  10. MacMahon B, Newill VA. Birth characteristics of children dying of malignant neoplasms. J Natl Cancer Inst 1962;28:231-44.
  11. Daling JR, Starzyk P, Olshan AF, Weiss NS. Birth weight and the incidence of childhood cancer. J Natl Cancer Inst 1984; 72:1039-41.
  12. Wilkins JR, Sinks TH. Paternal occupation and Wilms' tumour in offspring. J Epidemiol Community Health 1984;38:7-11.
  13. Bunin GR, Kramer S, Marrero O, Meadows AT, Annegers JF, Kurland LT, Hauser WA. Gestational risk factors for Wilms' tumor: results of a case-control study. Cancer Res 1987;47:2972-7.
  14. Olshan AF, Breslow NE, Falletta JM, Grufferman S, Pendergrass T, Robison LL, Waskerwitz M, Woods WG, Vietti TJ, Hammond GD. Risk factors for Wilms tumor. Report from the National Wilms Tumor Study. Cancer 1993;72:938-44.
  15. Heuch JM, Heuch I, Kvale G. Birth characteristics and risk of Wilms' tumour: a nationwide prospective study in Norway. Br J Cancer 1996;74:1148-51.
  16. Yeazel MW, Ross JA, Buckley JD, Woods WG, Ruccione K, Robison LL. High birth weight and risk of specific childhood cancers: a report from the Children's Cancer Group. J Pediatr 1997;131:671-7.
  17. Smulevich VB, Solionova LG, Belyakova SV. Parental occupation and other factors and cancer risk in children. I. Study methodology and non-occupational factors. Int J Cancer 1999;83:712-17.
  18. Schu ¨z J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J. High-birth weight and other risk factors for Wilms tumour: results of a population-based case-control study. Eur J Pediatr 2001;160:333-8.
  19. Okcu MF, Goodman KJ, Carozza SE, Weiss NS, Burau KD, Bleyer WA, Cooper SP. Birth weight, ethnicity, and occurrence of cancer in children: a population-based, incident case-control study in the State of Texas, USA. Cancer Causes Control 2002; 13:595-602.
  20. Lee J, Chia KS, Cheung KH, Chia SE, Lee HP. Birthweight and the risk of early childhood cancer among Chinese in Singapore. Int J Cancer 2004;110:465-7.
  21. Schu ¨z J, Forman MR. Birthweight by gestational age and childhood cancer. Cancer Causes Control 2007;18:655-63.
  22. Puumala SE, Soler JT, Johnson KJ, Spector LG. Birth characteristics and Wilms tumor in Minnesota. Int J Cancer 2008;122: 1368-73.
  23. Laurvick CL, Milne E, Blair E, de Klerk N, Charles AK, Bower C. Fetal growth and the risk of childhood non-CNS solid tumours in Western Australia. Br J Cancer 2008;99:179-81.
  24. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993;362:747-9.
  25. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993;362:749-51.
  26. Morison IM, Becroft DM, Taniguchi T, Woods CG, Reeve AE. Somatic overgrowth associated with overexpression of insulin- like growth factor II. Nat Med 1996;2: 311-16.
  27. Olshan AF. Wilms' tumor, overgrowth, and fetal growth factors: a hypothesis. Cancer Genet Cytogenet 1986;21:303-7.
  28. Reeve AE. Role of genomic imprinting in Wilms' tumour and overgrowth disorders. Med Pediatr Oncol 1996;27:470-5.
  29. Schmidt LS, Schu ¨z J, La ¨hteenma ¨ki P, Tra ¨ger C, Stokland T, Gustafson G, Hjalgrim L, Sehested A, Johansen C, Schmiegelow K. Fetal growth, preterm birth, neonatal stress and risk for CNS tumors in children: a Nordic population- and register-based case-control study. Cancer Epidemiol Biomarkers Prev, 2010; 19:1042-52.
  30. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer 2005;103:1457-67.
  31. Tulinius H, Storm HH, Pukkala E, Andersen A, Ericsson J. Cancer in the Nordic countries, 1981-86. A joint Birth characteristics and Wilms tumors in children Int. J. Cancer: 128, 2166-2173 (2011) V C 2010 UICC publication of the five Nordic Cancer Registries. APMIS Suppl 1992;31:1-194.
  32. Gissler M, Louhiala P, Hemminki E. Nordic Medical Birth Registers in epidemiological research. Eur J Epidemiol 1997;13:169-75.
  33. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 2003;111:1253-61.
  34. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85:843-8.
  35. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. NC, USA: SAS Institute Inc., 1995.
  36. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995;6: 356-65.
  37. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 1953;32:260-7.
  38. Thorngren-Jerneck K, Herbst A. Low 5- minute Apgar score: a population-based register study of 1 million term births. Obstet Gynecol 2001;98:65-70.
  39. Ruan K, Song G, Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 2009;107:1053-62.
  40. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008;15:678-85.
  41. Makri T, Yakoumakis E, Papadopoulou D, Gialousis G, Theodoropoulos V, Sandilos P, Georgiou E. Radiation risk assessment in neonatal radiographic examinations of the chest and abdomen: a clinical and Monte Carlo dosimetry study. Phys Med Biol 2006;51:5023-33.
  42. Sadetzki S, Mandelzweig L. Childhood exposure to external ionising radiation and solid cancer risk. Br J Cancer 2009; 100:1021-5.
  43. Spector LG, Klebanoff MA, Feusner JH, Georgieff MK, Ross JA. Childhood cancer following neonatal oxygen supplementation. J Pediatr 2005;147: 27-31.
  44. Little J. Epidemiology of childhood cancer. IARC Scientific Publications No. 149. Lyon, France: IARC Press, 1999.
  45. Johnson KJ, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC, Mueller BA, Puumala SE, Reynolds P, Von Behren J, Spector LG. Parental age and risk of childhood cancer: a pooled analysis. Epidemiology 2009;20:475-83.
  46. Yip BH, Pawitan Y, Czene K. Parental age and risk of childhood cancers: a population-based cohort study from Sweden. Int J Epidemiol 2006;35:1495-503.